American Factories Are Automating. Automated Industrial Robotics Is Focused on Whether They Are Doing It Well.
Written by Ethan M. Stone
The case for automation in American manufacturing has become close to self-evident. Labor markets in key production sectors have tightened considerably over the past decade, and the structural factors driving that tightening are not expected to reverse. At the same time, production complexity has increased across industries including pharmaceuticals, precision components, and advanced assembly, creating environments where the requirements for consistency and accuracy have grown more demanding even as the workforce available to meet them has contracted.
What receives less examination is the execution side of that picture. The decision to automate and the quality of the automation that results are distinct questions, and the gap between a well-deployed system and a poorly conceived one is measured in production losses, remediation timelines, and operational disruption that compounds across months rather than resolving quickly.
Automated Industrial Robotics (AIR) was founded in 2023 by Brian Klos, Executive Chairman, and Darragh de Stonndún, CEO, with a particular focus on the environments where execution quality matters most. The company serves pharmaceutical production facilities, precision assembly operations, and complex systems integration projects, working in contexts where the tolerance for error is extremely low and where the relationship between the automation provider and the facility operator needs to extend well past the point of initial deployment.
AIR has built its capability through a combination of internal development and acquisitions, with cultural alignment serving as the first and most determinative criterion in every expansion decision. The company assesses whether the people in a prospective organization share the values that drive how AIR works, specifically around collaborative problem-solving, genuine collective accountability, and sustained focus on customer outcomes. AIR has integrated multiple companies while maintaining strong team continuity, a result of how carefully those assessments are conducted and how seriously the findings are weighted.
The engineering depth that results from that approach is shared actively across the organization. Expertise developed in pharmaceutical automation informs how AIR approaches challenges in other sectors. Experience built in precision assembly contributes to how the company handles complex systems integration projects. That deliberate movement of knowledge across teams and geographies is what allows customers to access the full depth of AIR's collective experience on any given project, rather than only the expertise of the local team.
AIR was built on the conviction that sharing value creation across the teams doing the work produces organizations that perform better and endure longer than those structured around individual incentives and siloed delivery. AIR's systems are designed to improve accuracy over time, and the company provides an engineering-led deployment approach with ongoing support and optimization services that remain active throughout the customer relationship.
AIR is supported by long-term strategic investment enabling continued growth across North American manufacturing markets.
AIR focuses on the value delivered to customers while maintaining strict confidentiality around who it works with and how projects are executed.
